VMaerobics™ brain training exercises improve memory by 35%
VMaerobics™ brain training exercises improve memory by 35%
From aging adults to high-performing professionals, people everywhere want to protect and extend their mental agility. But today’s market is dominated by crossword puzzles, supplements, and unvalidated apps that promise results… without delivering measurable improvements.
VMaerobics™ changes that, introducing the first biomarker-driven brain training program accessible to anyone, anywhere.
By 2035, cognitive wellness solutions will represent a $63 billion global opportunity.
From seniors to performance-focused adults, millions seek brain tools with measurable outcomes.
Most brain training platforms fail to prove real outcomes. VMaerobics™ is different — built on patented technology, validated by independent research, and powered by a measurable cognitive biomarker: Vision Processing Speed. It’s science, not guesswork.
Most brain training platforms are entertainment-based and lack scientific validation. VMaerobics™ is built on a proven cognitive biomarker — Vision Processing Speed — with decades of research and measurable outcomes.
The platform is complete and preparing for launch in early 2026. We are currently in a friends-and-family fundraising phase (Sept–Dec 2025) before scaling to a consumer rollout.
While seniors remain a key early market, our audience is broader — including caregivers, health-conscious adults, and performance-focused professionals seeking sharper focus and mental agility.
VMaerobics™ is cloud-based. Users simply log in from any internet-connected computer and complete a 10-minute session from home — private, convenient, and accessible worldwide.
Subscription-based SaaS delivery. A free consumer version of VMdetect lets users test their baseline, while paid subscribers access the full VMaerobics™ program and track their progress.
Proprietary software with legacy patent protection, validated research partnerships, and a first-mover advantage in biomarker-driven brain health distinguish VMaerobics™ from unproven apps.
In 2024, U.S. consumers spent $19B on brain health tools. The global longevity market is projected to reach $63B by 2035. Demand is strong, but no validated consumer solution exists — until now.
To become the global standard for consumer brain health. Our roadmap includes expanding internationally, developing partnerships with healthcare organizations, and scaling into performance markets beyond seniors.
Backed by decades of independent research, VMaerobics™ is now positioned for rapid scale. Here’s how we move from proven science to global adoption.
Built on patented technology validated in independent studies, showing measurable improvements in vision, memory, and focus.
The VMaerobics™ platform is fully developed and preparing for consumer rollout, combining validated science with scalable delivery.
With fundraising underway, we are targeting early 2026 for full market introduction — beginning in the U.S. and expanding globally.
VMaerobics™ is built by neuroscientist and founder Richard Cheu, alongside a world-class advisory board spanning medicine, IT, law, and global markets. Together, they bring the expertise to scale a validated product into a global brand.
VMaerobics™ is poised to lead the global brain training market with the first biomarker-driven consumer platform. Backed by decades of research and built for scale, we’re inviting investors to partner with us at the ground floor of a massive growth opportunity.
